Skip to main content

Brain tumour awareness and research

EDM (Early Day Motion) 846: tabled on 07 September 2020

Tabled in the 2019-21 session.

This motion has been signed by 22 Members. It has not yet had any amendments submitted.

Motion text

That this House calls for an increase in both awareness of and research into brain tumours; notes that this type of cancer presently receives less than 3 per cent of the UK’s cancer research budget despite being the biggest cancer killer of children and adults under 40; specifically recognises the need to raise awareness of diffuse midline glioma, commonly known as DIPG, the second most common type of primary high-grade brain tumour found in British children; expresses concern that treatment for DIPG has been unchanged for almost 40 years, with only 10 per cent of children with DIPG surviving for more than 2 years following their diagnosis; understands that symptoms of DIPG include difficulty in speaking and walking, weakness of facial muscles, problems with eye movement, headaches, and nausea; welcomes the fantastic effort of Fiona Govan, whose e-petition to this parliament to generate more publicity for DIPG and to achieve further funding for a disease that presently has no cure has gained over 100,000 signatures; commends the valuable research and efforts of organisations such as the Brain Tumour Charity that is currently leading new drugs research to target, prevent, and treat DIPG; and urges the Government to increase funding dedicated to research into DIPG and to expand recognition and treatment of this distressing disease.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.